Overlap Syndromes

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Overlap syndromes are inflammatory rheumatic conditions in which patients have clinical manifestations suggestive of multiple distinct immune diseases. The diseases most commonly involved in overlap syndromes include rheumatoid arthritis, lupus, scleroderma, and myositis. The most well-characterized overlap syndrome, mixed connective tissue disease (MCTD), is defined by anti-RNP autoimmunity along with features of at least two of these four conditions, and very often includes sufficient lupus manifestations to fulfill the SLICC lupus classification criteria. Overlap syndromes are generally less common than the conditions they encompass; the prevalence of MCTD, for example, is approximately one-twentieth that of SLE. Some autoantigen systems are particularly linked with overlap syndromes, such as RNP in MCTD. Overlap syndromes provide unique opportunities to understand links between autoimmunity and end organ immune targeting. While insights can be extrapolated from studies of disease processes present in overlap, few treatment trials have focused specifically on overlap syndromes themselves.

Original languageEnglish (US)
Title of host publicationSystemic Lupus Erythematosus: Basic, Applied and Clinical Aspects
PublisherElsevier Inc.
Pages425-430
Number of pages6
ISBN (Print)9780128020098, 9780128019177
DOIs
StatePublished - 2016

Fingerprint

Mixed Connective Tissue Disease
Autoimmunity
Myositis
Immune System Diseases
Autoantigens
Rheumatoid Arthritis
Therapeutics

Keywords

  • Mixed connective tissue disease
  • Myositis
  • Rheumatoid arthritis
  • RNP
  • Scleroderma

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Greidinger, E. L. (2016). Overlap Syndromes. In Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects (pp. 425-430). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-801917-7.00048-6

Overlap Syndromes. / Greidinger, Eric L.

Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects. Elsevier Inc., 2016. p. 425-430.

Research output: Chapter in Book/Report/Conference proceedingChapter

Greidinger, EL 2016, Overlap Syndromes. in Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects. Elsevier Inc., pp. 425-430. https://doi.org/10.1016/B978-0-12-801917-7.00048-6
Greidinger EL. Overlap Syndromes. In Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects. Elsevier Inc. 2016. p. 425-430 https://doi.org/10.1016/B978-0-12-801917-7.00048-6
Greidinger, Eric L. / Overlap Syndromes. Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects. Elsevier Inc., 2016. pp. 425-430
@inbook{3445d71a9d6a471db9e836fabdf861bf,
title = "Overlap Syndromes",
abstract = "Overlap syndromes are inflammatory rheumatic conditions in which patients have clinical manifestations suggestive of multiple distinct immune diseases. The diseases most commonly involved in overlap syndromes include rheumatoid arthritis, lupus, scleroderma, and myositis. The most well-characterized overlap syndrome, mixed connective tissue disease (MCTD), is defined by anti-RNP autoimmunity along with features of at least two of these four conditions, and very often includes sufficient lupus manifestations to fulfill the SLICC lupus classification criteria. Overlap syndromes are generally less common than the conditions they encompass; the prevalence of MCTD, for example, is approximately one-twentieth that of SLE. Some autoantigen systems are particularly linked with overlap syndromes, such as RNP in MCTD. Overlap syndromes provide unique opportunities to understand links between autoimmunity and end organ immune targeting. While insights can be extrapolated from studies of disease processes present in overlap, few treatment trials have focused specifically on overlap syndromes themselves.",
keywords = "Mixed connective tissue disease, Myositis, Rheumatoid arthritis, RNP, Scleroderma",
author = "Greidinger, {Eric L}",
year = "2016",
doi = "10.1016/B978-0-12-801917-7.00048-6",
language = "English (US)",
isbn = "9780128020098",
pages = "425--430",
booktitle = "Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Overlap Syndromes

AU - Greidinger, Eric L

PY - 2016

Y1 - 2016

N2 - Overlap syndromes are inflammatory rheumatic conditions in which patients have clinical manifestations suggestive of multiple distinct immune diseases. The diseases most commonly involved in overlap syndromes include rheumatoid arthritis, lupus, scleroderma, and myositis. The most well-characterized overlap syndrome, mixed connective tissue disease (MCTD), is defined by anti-RNP autoimmunity along with features of at least two of these four conditions, and very often includes sufficient lupus manifestations to fulfill the SLICC lupus classification criteria. Overlap syndromes are generally less common than the conditions they encompass; the prevalence of MCTD, for example, is approximately one-twentieth that of SLE. Some autoantigen systems are particularly linked with overlap syndromes, such as RNP in MCTD. Overlap syndromes provide unique opportunities to understand links between autoimmunity and end organ immune targeting. While insights can be extrapolated from studies of disease processes present in overlap, few treatment trials have focused specifically on overlap syndromes themselves.

AB - Overlap syndromes are inflammatory rheumatic conditions in which patients have clinical manifestations suggestive of multiple distinct immune diseases. The diseases most commonly involved in overlap syndromes include rheumatoid arthritis, lupus, scleroderma, and myositis. The most well-characterized overlap syndrome, mixed connective tissue disease (MCTD), is defined by anti-RNP autoimmunity along with features of at least two of these four conditions, and very often includes sufficient lupus manifestations to fulfill the SLICC lupus classification criteria. Overlap syndromes are generally less common than the conditions they encompass; the prevalence of MCTD, for example, is approximately one-twentieth that of SLE. Some autoantigen systems are particularly linked with overlap syndromes, such as RNP in MCTD. Overlap syndromes provide unique opportunities to understand links between autoimmunity and end organ immune targeting. While insights can be extrapolated from studies of disease processes present in overlap, few treatment trials have focused specifically on overlap syndromes themselves.

KW - Mixed connective tissue disease

KW - Myositis

KW - Rheumatoid arthritis

KW - RNP

KW - Scleroderma

UR - http://www.scopus.com/inward/record.url?scp=84966929736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966929736&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801917-7.00048-6

DO - 10.1016/B978-0-12-801917-7.00048-6

M3 - Chapter

AN - SCOPUS:84966929736

SN - 9780128020098

SN - 9780128019177

SP - 425

EP - 430

BT - Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects

PB - Elsevier Inc.

ER -